Search results
22 kwi 2022 · Today, WHO made a strong recommendation for nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate COVID-19 patients at highest risk of hospital admission, calling it the best therapeutic choice for high-risk patients to date.
- COVID-19 Treatments - World Health Organization (WHO)
Thousands of trials investigating COVID-19 interventions...
- WHO recommends two new drugs to treat COVID-19
Studies are ongoing on the effectiveness of monoclonal...
- COVID-19 Treatments - World Health Organization (WHO)
13 cze 2024 · Thousands of trials investigating COVID-19 interventions have been registered or are ongoing. WHO, through its COVID-19 Solidarity Therapeutics Trial, is coordinating global efforts to find drugs and other therapies that can save lives for those with severe or critical COVID-19.
16 cze 2021 · Exactly a year on from the discovery that a cheap steroid drug prevented Covid deaths, researchers say they have found another life-saving therapy. It is expensive - a potent intravenous infusion...
14 sty 2022 · Studies are ongoing on the effectiveness of monoclonal antibodies against Omicron but early laboratory studies show that sotrovimab retains its activity. The panel of experts developing the guidelines also looked at two other drugs for severe and critical COVID-19: ruxolitinib and tofacitinib.
15 mar 2022 · Vaccines have transformed the pandemic, but there is still a huge need for drugs which can treat Covid. Immunity from vaccines can wane, and access is still a major problem around the world....
3 maj 2023 · What are the best treatments for covid-19? Written in cooperation with the World Health Organization, The BMJ’s living systematic review is a meta-analysis comparing the effects of treatments for covid-19,1 using data from more than 400 randomised clinical trials worldwide.
23 mar 2021 · Dexamethasone, an inexpensive and widely available steroid, has saved around one million lives worldwide since its discovery as an effective treatment for COVID-19 in a clinical trial in the NHS.
